Bioresorbable vascular scaffolds in ST-elevation myocardial infarction – OCT-guided implantation and mid-term OCT resultsd

Bioresorbable vascular scaffolds in ST-elevation myocardial infarction – OCT-guided implantation and mid-term OCT resultsd - DESolve-STEMI-OCT

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

DRKS

Registry ID

DRKS00009788

Enrollment

Registered

2015-12-15

Start date

2016-03-22

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I21

Interventions

Group 1: STEMI DESolve (bioresorbable vascular scaffolds (BRS) in Patient with ST-Segment myocardial Infarction (STEMI). Every Patient with STEMI and BRS is enrolled in the study. Additional the Patie

Eligibility

Sex/Gender

All

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: -All Patients with STEMI and with a anatomically suitable coronarstatus -Written agreement of the Patient

Exclusion criteria

Exclusion criteria: -Intellectual reduction, No suitable coronarstatus (ostial leasion, bifurcation, calc rich leasions)

Design outcomes

Secondary

Measure	Time frame
-TIMI 0, I, II, III Fluss -Angina Pectoris -Successfull Stent-Implantationen -Target vessel failure (cardiac death, target vessel MI, or clinically driven target vessel revascularisation (TVR), and scaffold thrombosis (ST)) -Kidneyinjury -Rhythm-Events	—

Primary

Measure	Time frame
device-oriented composite endpoint within 36 Month (target lesion failure [TLF]), defined as the combination of cardiac death, target vessel MI, or clinically driven target lesion revascularisation (TLR), either percutaneous or surgical. Deaths that could not be attributed to another cause were re-garded as cardiac deaths. OCT subgroup: neointima formation after 4-6 month	—

Countries

Germany

Contacts

Public ContactFelix Hauptmann

Brüderkrankenhaus Trier

f.hauptmann@bk-trier.de01736400438

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026